1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Abeona Therapeutics Inc.

Abeona Therapeutics Inc.

ABEO
Abeona Therapeutics Inc.US flagNASDAQ Capital Market
6.53
USD
+0.05
- -
372.18MMarket Cap

Total Valuation

Abeona Therapeutics Inc. carries a market capitalization of 372.18M, placing it among publicly traded companies globally. Its enterprise value stands at 98.89M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap372.18M
Enterprise Value98.89M

Share Statistics

Abeona Therapeutics Inc. currently has 56.87M shares outstanding.

Shares Outstanding56.87M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Abeona Therapeutics Inc. trades at a trailing price-to-earnings ratio of 3.69. The price-to-sales ratio is 16.78, and the price-to-book ratio stands at -0.32.

PE Ratio3.69
PS Ratio16.78
PB Ratio-0.32
P/TBV Ratio1.68
P/FCF Ratio-3.41
P/OCF Ratio-3.14

Enterprise Valuation

EV / Sales6.80
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

Abeona Therapeutics Inc. maintains a current ratio of 5.89, meaning it holds 5.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 15.99, indicating elevated leverage, while an interest coverage ratio of -24.95 demonstrates limited ability to service its debt obligations.

Current Ratio5.89
Quick Ratio5.64
Debt / Equity15.99
Debt / EBITDA-0.26
Interest Coverage-24.95

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)44.41
Return on Invested Capital (ROIC)-79.33
Return on Capital Employed (ROCE)-9.07
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.02

Taxes

Over the trailing twelve months, Abeona Therapeutics Inc. has paid 102,000.00 in income taxes, reflecting an effective tax rate of 0.15.

Income Tax102,000.00
Effective Tax Rate0.15

Stock Price Statistics

Abeona Therapeutics Inc.'s stock has declined approximately -3.25926% over the past 52 weeks. The 50-day moving average sits at 5.92, while the 200-day moving average is 5.28.

Beta (5Y)N/A
52-Week Price Change-3.25926%
50-Day Moving Average5.92
200-Day Moving Average5.28
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Abeona Therapeutics Inc. generated 14.54M in revenue and converted that into 66.14M in net income, yielding earnings per share of 1.12. EBITDA reached -89.14M, while operating income came in at -92.75M.

Revenue14.54M
Gross Profit8.42M
Operating Income-92.75M
Pretax Income66.24M
Net Income66.14M
EBITDA-89.14M
EBIT-92.75M
Earnings Per Share (EPS)1.12

Balance Sheet

Abeona Therapeutics Inc. holds 168.27M in cash and equivalents against 23.17M in total debt, resulting in a net debt position of -43.29M. Total book value stands at -758.58M, with working capital of 151.94M providing operational flexibility.

Cash & Cash Equivalents168.27M
Total Debt23.17M
Net Debt-43.29M
Equity (Book Value)-758.58M
Book Value Per Share-13.93
Working Capital151.94M

Cash Flow

Abeona Therapeutics Inc. produced -77.73M in operating cash flow over the past twelve months.

Operating Cash Flow-77.73M
Capital ExpendituresN/A
Free Cash Flow-77.73M
FCF Per Share-1.43

Margins

Abeona Therapeutics Inc. operates with a gross margin of 57.90, reflecting its pricing power and cost economics. The operating margin of -637.92 and net profit margin of 454.86 provide insight into operational efficiency.

Gross Margin57.90
Operating Margin-637.92
Pretax Margin455.56
Profit Margin454.86
EBITDA Margin-613.05

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-6.99
FCF Yield-29.32

Stock Splits

Abeona Therapeutics Inc.'s most recent stock split took place on July 5, 2022 with a 25:1 split ratio.

Last Split Date7/5/2022
Split Ratio25:1

Scores

Abeona Therapeutics Inc. posts an Altman Z-Score of -3.17, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.17